Literature DB >> 30924968

Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Claudia J Posso-De Los Rios1, Akua Sarfo2, Mondana Ghias3, Raed Alhusayen4, Iltefat Hamzavi5, Michelle A Lowes6, Afsaneh Alavi1.   

Abstract

The 3rd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 12-14 October 2018 at the Women's College Hospital in Toronto, Ontario, Canada. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF) founded in the USA and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This cross-disciplinary meeting with experts from around the world was an opportunity to discuss the most recent advances in the study of hidradenitis suppurativa pathogenesis, epidemiology, classification, scoring systems, radiologic diagnosis, treatment approaches and psychologic assessment. Two special sessions this year were HS as a systemic disease and HS management guidelines. There were focused workshops on wound healing and ultrasound. There were two sessions primarily for patients and their families in the HS School programme: One workshop focused on mindfulness, and the second involved discussion among clinicians and patients about various disease aspects and the latest management. To facilitate networking between clinical and research experts and those early in their career, a mentoring breakfast was held.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  classification; diagnosis; epidemiology; pathogenesis; treatment

Year:  2019        PMID: 30924968      PMCID: PMC6800012          DOI: 10.1111/exd.13928

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  54 in total

1.  Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.

Authors:  Schapoor Hessam; Michael Sand; Marina Skrygan; Thilo Gambichler; Falk G Bechara
Journal:  J Dermatol Sci       Date:  2016-02-18       Impact factor: 4.563

2.  Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study.

Authors:  Allard R J V Vossen; Kelsey R van Straalen; Errol P Prens; Hessel H van der Zee
Journal:  J Am Acad Dermatol       Date:  2017-01       Impact factor: 11.527

3.  Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach.

Authors:  L M Valladares-Narganes; M A Rodríguez-Prieto; M D Blanco-Suárez; C Rodriguez-Lage; I García-Doval
Journal:  Br J Dermatol       Date:  2015-02-25       Impact factor: 9.302

4.  Low and high body mass index in hidradenitis suppurativa patients-different subtypes?

Authors:  P Theut Riis; D M Saunte; F Benhadou; V Del Marmol; P Guillem; M El-Domyati; H Abdel-Wahab; C Antoniou; C Dessinioti; M A Gürer; B Beksaç; J C Szepietowski; L Matusiak; L Emtestam; J Lapins; H Riad; N Doss; A F Massa; I Hamzavi; C Nicholson; M Dolenc-Voljc; K H Kim; J Ohn; C C Zouboulis; I Karagiannidis; Z B Mokos; P Durinec; G B E Jemec
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-10-10       Impact factor: 6.166

5.  The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls.

Authors:  Hans Christian Ring; Jonathan Thorsen; Ditte M Saunte; Berit Lilje; Lene Bay; Peter Theut Riis; Niels Larsen; Lee O'Brien Andersen; Henrik V Nielsen; Iben M Miller; Thomas Bjarnsholt; Kurt Fuursted; Gregor Borut Jemec
Journal:  JAMA Dermatol       Date:  2017-09-01       Impact factor: 10.282

Review 6.  Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa.

Authors:  C Lavogiez; E Delaporte; S Darras-Vercambre; E Martin De Lassalle; C Castillo; X Mirabel; F Laurent; P Patenotre; T Gheit; J C Talmant; M Beylot-Barry; V Martinot; F Piette; F Aubin; L Mortier
Journal:  Dermatology       Date:  2009-12-23       Impact factor: 5.366

7.  Hidradenitis suppurativa--characteristics and consequences.

Authors:  G B Jemec; M Heidenheim; N H Nielsen
Journal:  Clin Exp Dermatol       Date:  1996-11       Impact factor: 3.470

8.  Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa.

Authors:  E Shavit; J Dreiher; T Freud; S Halevy; S Vinker; A D Cohen
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-06-09       Impact factor: 6.166

9.  European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.

Authors:  C C Zouboulis; N Desai; L Emtestam; R E Hunger; D Ioannides; I Juhász; J Lapins; L Matusiak; E P Prens; J Revuz; S Schneider-Burrus; J C Szepietowski; H H van der Zee; G B E Jemec
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-01-30       Impact factor: 6.166

10.  Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.

Authors:  Alexa B Kimball; Martin M Okun; David A Williams; Alice B Gottlieb; Kim A Papp; Christos C Zouboulis; April W Armstrong; Francisco Kerdel; Michael H Gold; Seth B Forman; Neil J Korman; Evangelos J Giamarellos-Bourboulis; Jeffrey J Crowley; Charles Lynde; Ziad Reguiai; Errol-Prospero Prens; Eihab Alwawi; Nael M Mostafa; Brett Pinsky; Murali Sundaram; Yihua Gu; Dawn M Carlson; Gregor B E Jemec
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

View more
  2 in total

Review 1.  Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.

Authors:  Puneet Agarwal; Snehal Balvant Lunge; Nandini Sundar Shetty; Priyanka Karagaiah; Steven Daveluy; Alex G Ortega-Loayza; Thrasyvoulos Tzellos; Jacek C Szepietowski; Christos C Zouboulis; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

Review 2.  Hidradenitis Suppurativa: Surgical and Postsurgical Management.

Authors:  Marco Manfredini; Federico Garbarino; Laura Bigi; Giovanni Pellacani; Cristina Magnoni
Journal:  Skin Appendage Disord       Date:  2020-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.